RVT-101 improved cognition and function when combined with donepezil in patients with mild to moderate Alzheimer’s disease.
All articles by Kathleen Tulley, Editorial Director
Investigators identified a possible disease-modifying effect of solanezumab as an early treatment for Alzheimer’s disease, but the benefit in clinical practice remains unclear.
Latest News Your top articles for FridayFor More Personalized News
Haymarket Medical NetworkTop Picks
Continuing Medical Education (CME/CE) Courses